Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gilead Sciences
(NQ:
GILD
)
115.03
+0.80 (+0.70%)
Streaming Delayed Price
Updated: 10:58 AM EDT, Jul 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gilead Sciences
< Previous
1
2
3
4
5
6
7
8
9
...
62
63
Next >
Why Gilead Sciences Stock Slipped Today
July 28, 2025
Changes in a federal healthcare authority could negatively impact one of the company's important businesses.
Via
The Motley Fool
BMO Capital Has An Important Take On Gilead Sciences, Retail’s Keeping The Optimism Alive
July 28, 2025
The Supreme Court's Braidwood decision only concretized the power of the Department of Health and Human Services to decide what is necessary preventative care, rather than outright protecting...
Via
Stocktwits
Visa, Disney, Blackstone And A Health Care Stock On CNBC's 'Final Trades'
July 28, 2025
Visa, which will report third quarter results on Tuesday, July 29, is analyst Stephanie Link's final trade.
Via
Benzinga
Why Gilead Sciences (GILD) Stock Is Up Today
July 25, 2025
Shares of biopharmaceutical company Gilead Sciences (NASDAQ:GILD) jumped 3% in the afternoon session after its long-acting HIV prevention injection, lenacapavir, received a recommendation for approval...
Via
StockStory
Topics
Stocks
World Trade
Price Over Earnings Overview: Gilead Sciences
July 25, 2025
Via
Benzinga
Why Gilead Sciences Stock Just Popped
July 25, 2025
Gilead stock is flashing "buy" in bright green letters.
Via
The Motley Fool
Gilead's Newly Approved HIV Prevention Drug Poised To Add Billions To Future Sales
July 25, 2025
Gilead upgraded to Buy by Needham as Yeztugo gains physician favor, with sales forecast to reach $6.4 billion by 2035, exceeding prior estimates.
Via
Benzinga
This Gilead Sciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
July 25, 2025
Via
Benzinga
Gilead Gets Analyst Thumbs Up On Market Potential Of HIV-Prevention Injection, But Retail’s Not Ready To Cheer Yet
July 25, 2025
Needham has a $133 price target on the stock, representing an upside of about 17.5% to the stock’s closing price on Thursday.
Via
Stocktwits
Topics
Workforce
Gilead Receives Positive CHMP Opinions Under Accelerated Review From European Medicines Agency for Twice-Yearly Lenacapavir for HIV Prevention
July 25, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences to Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
July 24, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
1 Value Stock Worth Your Attention and 2 Facing Headwinds
July 24, 2025
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...
Via
StockStory
Topics
Supply Chain
Director Sells 11,136 Shares of SRRK, a Stock Up 330% in Past Year
July 23, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Gilead Sciences, Omnicom Group, and QuinStreet Shares Skyrocket, What You Need To Know
July 23, 2025
A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally.
Via
StockStory
Topics
Stocks
World Trade
NAFA Publishes New Fleet Safety Guidebook Aimed at Developing Safety-First Culture in all Organizations
July 23, 2025
Comtex News Network, Inc. is a content specialist offering actionable news distribution, global syndication, and traffic for your content
Via
News Direct
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
July 23, 2025
From
Pomerantz LLP
Via
GlobeNewswire
2 Large-Cap Stocks to Consider Right Now and 1 That Underwhelm
July 21, 2025
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...
Via
StockStory
Topics
Supply Chain
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
July 18, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Expanding the Preventive Care Frontier: Dr. Reddy’s Launches Sanofi’s Beyfortus® in India
July 17, 2025
Via
AB Newswire
Topics
Death
Q1 Earnings Roundup: Gilead Sciences (NASDAQ:GILD) And The Rest Of The Therapeutics Segment
July 15, 2025
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including Gilead Sciences (NASDAQ:GILD) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Which S&P500 stocks are gapping on Tuesday?
July 15, 2025
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Tuesday to find the gap up and gap down stocks in today's session.
Via
Chartmill
GILD Investors Have Opportunity to Join Gilead Sciences, Inc. Fraud Investigation with the Schall Law Firm
July 14, 2025
From
The Schall Law Firm
Via
Business Wire
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
July 14, 2025
Via
Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Gilead Sciences, Inc. - GILD
July 14, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Gilead Presents New Data on Twice-Yearly Lenacapavir (Yeztugo®) for HIV Prevention at IAS 2025
July 14, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
GILEAD SCIENCES INC (NASDAQ:GILD) – An Undervalued Biopharmaceutical Stock Worth Considering
July 12, 2025
GILEAD SCIENCES INC (NASDAQ:GILD) appears undervalued with strong profitability and reasonable financial health, making it a potential candidate for value investors.
Via
Chartmill
Bill Gates Warns Of 'Devestating Effects' Of USAID Funding Cuts: 'It's Not Too Late To Reverse Them'
July 12, 2025
Bill Gates raises concerns over U.S. aid cuts' impact on HIV programs in Africa and calls for a reversal of the decision.
Via
Benzinga
Guardant Health, Gilead Sciences, Inspire Medical Systems, Enovis, and AMN Healthcare Services Stocks Trade Down, What You Need To Know
July 11, 2025
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada.
Via
StockStory
Topics
ETFs
Stocks
World Trade
Top S&P500 movers in Friday's session
July 11, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top S&P500 gainers and losers in today's session.
Via
Chartmill
What's going on in today's session: S&P500 movers
July 11, 2025
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
62
63
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.